Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

In Vitro Toxicology Testing Market To Grow USD 16460 Million by 2028 At A CAGR Of 6.5%| Valuates Reports

This image opens in the lightbox

News provided by

Valuates Reports

25 Nov, 2022, 13:00 GMT

Share this article

Share toX

Share this article

Share toX

BANGALORE, India, Nov. 25, 2022 /PRNewswire/ -- In Vitro Toxicology Testing Market is segmented by type (Cellular Assay, Biochemical Assay, In Silica, Ex-vivo), by application (Systemic Toxicology, Dermal Toxicity, Endocrine Disruption, Ocular Toxicity, Others) : Opportunity Analysis and Industry Forecast, 2022–2028. It is published in Valuates Reports under the Pharmaceuticals & Biotech Category.

The global In vitro Toxicology Testing market size is projected to reach USD 16460 million by 2028, from USD 10560 million in 2021, at a CAGR of 6.5% during 2022-2028.

Major Factors Driving the Growth of In Vitro Toxicology Testing Market

One of the main trends fueling market expansion is factors like technical advancements. In addition, socio-ethical issues surrounding animal testing and the high costs of traditional animal testing are expected to increase the preference for in vitro toxicological assays. Increasing R&D spending to identify toxicity early on in the drug development process is another factor driving the In vitro Toxicology Testing market expansion.

New compound toxicity testing is crucial for the process of developing drugs. The toxic effects of an investigational product are identified by species-, organ-, and dose-specific preclinical toxicity testing on various biological systems.

Browse The Detailed Report: https://reports.valuates.com/market-reports/QYRE-Auto-9G1984/global-in-vitro-toxicology-testing

TRENDS INFLUENCING THE GROWTH OF THE IN VITRO TOXICOLOGY TESTING MARKET

In vitro toxicology screening approaches are key tools to decrease the attrition of novel drug candidates as they progress through the discovery and development process. A great deal of discussion within the toxicology community focuses on the need to adapt existing toxicity testing paradigms to decrease reliance on traditional animal testing and increase reliance upon alternative methods, including in vitro high-throughput screening (HTS) and predictive toxicology based on computational approaches. Prior to IND approval, drug candidates must go through a comprehensive battery of in vitro and in vivo toxicology testing to maximize safety in clinical trials. For ethical reasons and the costly nature of the in vivo animal tests, the pharmaceutical industry relies more and more on in vitro methods for toxicity testing, especially in the drug discovery phase. This factor is expected to drive the growth of the In vitro Toxicology Testing market

A large number of research studies and drug development projects for COVID-19 are anticipated to accelerate the market for in vitro toxicity testing because these studies can assist reduce liabilities connected to late-stage failure in the drug discovery process. By November 2020, there were many COVID-19 medications in various stages of research. The need for in vitro toxicity testing services is predicted to increase as a result of a large number of drug development initiatives. Thus, the COVID-19 recent covid-19 outbreak will further fuel the In vitro Toxicology Testing market

Companies in the pharmaceutical, cigarette, nutraceutical, cosmetic, and agrochemical industries frequently need to detect risks related to product inhalation. Understanding chemical safety requires an evaluation of normal lung function since many chemical agents enter the body through inhalation. Many businesses that want to do inhalation studies employ animal testing to determine a compound's possible effects on the lung, but these tests are expensive and human inhalation studies are not ethically possible. Businesses can comprehend in vivo toxicity following chemical exposure using a human in vitro lung model without incurring the additional expense of conventional animal testing.

Due to a need for biological test systems and the desire to avoid using animals in the study, the use of cell and tissue culture techniques in research and industry is growing quickly. In toxicology, biosafety concerns have typically been concentrated on the test substances and the lab equipment. There are standardized methods for evaluating the risks associated with these materials and safeguarding laboratory workers from dangerous chemicals. For screening and ranking chemicals, in vitro methods are frequently used. They have also occasionally been considered for risk assessment purposes when it comes to food additives. This in turn is expected to drive the growth of the In vitro Toxicology Testing market.

A rapidly developing discipline called tissue engineering seeks to develop workable methods for creating biologically similar substitutes for diseased and damaged tissues and organs. This possibility has led to the creation of in vitro organ models for medication toxicity evaluation. There is a demand for physiologically appropriate in vitro models of the eye to evaluate drug delivery and the safety of new ocular medicines due to the rise in new ophthalmic treatments and the ongoing interest in ocular drug delivery as a route for administration. This will fuel the In vitro Toxicology Testing market.

Get Your Sample Report Today: https://reports.valuates.com/request/sample/QYRE-Auto-9G1984/Global_In_vitro_Toxicology_Testing_Market 

IN VITRO TOXICOLOGY TESTING MARKET SHARE ANALYSIS:

During the projected period, the Asia Pacific in vitro toxicity testing market is anticipated to develop at the highest CAGR. In the Asia Pacific, in vitro toxicology testing is becoming more popular. This is because of the opposition to animal testing that led to the use of alternative methodologies, the growth of CROs, increased consumer concern about product safety, and an expanding pharmaceutical medication pipeline.

The In vitro Toxicology Testing Market share belonged to the cell culture technology segment based on type. The most frequently used method for testing for toxicity is cell culture technology. One of the key reasons influencing the development of cell culture technology is its capacity to express the same genes and proteins as their in vivo counterparts.

Buy Regional Market Chapter On North America:

https://reports.valuates.com/market-reports/QYRE-Auto-9G1984/global-in-vitro-toxicology-testing/6

Buy Regional Market chapter On Asia Pacific:

https://reports.valuates.com/market-reports/QYRE-Auto-9G1984/global-in-vitro-toxicology-testing/8

Key Companies:

  • SGS Ltd
  • Covance
  • Bio Rad Laboratories
  • Qiagen NV
  • GE Healthcare
  • Eurofins Scientific
  • Merck
  • Thermo Fisher
  • Charles River Laboratories International
  • Catalent
  • Cyprotex
  • Promega
  • Gentronix Limited
  • Ascendance Biotechnology
  • MB Research Laboratories
  • China
  • Charles River Laboratories
  • India
  • Abbott
  • Quest Diagnostics Inc.
  • Thermo Fisher Scientific Inc
  • Catalent Pharma Solutions
  • Agilent Technologies
  • Merck KGaA
  • Eurofins Scientific Inc

Buy Chapter On Company Profiles: https://reports.valuates.com/market-reports/QYRE-Auto-9G1984/global-in-vitro-toxicology-testing/11

Buy Now for Single User + Covid-19 Impact: https://reports.valuates.com/api/directpaytoken?rcode=QYRE-Auto-9G1984lic=single-user

SUBSCRIPTION

We have introduced a tailor-made subscription for our customers. Please leave a note in the Comment Section to know about our subscription plans.

SIMILAR REPORTS:

-  Medical In-Vitro Toxicology Testing Market

-  ADME-Toxicology Testing Market

-  Radioimmunoassay Kits Market

-  Non-GLP Acute Toxicology Market

-  Clinical Mass Spectrometry Market

-  Genotoxicity Testing Service Market

-  Microchips 3D Cell Culture Market

-  Clinical Biomarker Testing Market

-  Immunoprotein Diagnostic Testing Market

-  Drug Testing System Market

-  Benzyl Piperazine Dihydrochloride Market

-  Specimen Validity Testing Market

-  Drug Delivery Systems Market

-  Cytotoxic Drug Safety Cabinet Market

-  Drug Tests Services Market

-  Roadside Drug Testing Device Market

-  Extended Release Drug Market

-  Wearable Injectors Market

-  Durable Medical Equipment (DME) Market

-  Tenecteplase Drugs Market

-  Atopic Dermatitis Drugs Market

-  Biological Safety Cabinet Market

-  Allergy Immunotherapy Market

-  A.V. Fistula Needle Set Market

-  Vein Finder Market

-  Transdermal Patch Market

-  Surgical Imaging Market

-  CBCT Dental Imaging Market

-  Veterinary Healthcare Market

-  Veterinary Vaccine Market

-  Cleanroom Technology Market

-  Healthcare IT Market

Click here to see related reports on the In-vitro Toxicology Testing Market

ABOUT US:

Valuates offers in-depth market insights into various industries. Our extensive report repository is constantly updated to meet your changing industry analysis needs.

Our team of market analysts can help you select the best report covering your industry. We understand your niche region-specific requirements and that's why we offer customization of reports. With our customization in place, you can request any particular information from a report that meets your market analysis needs.

To achieve a consistent view of the market, data is gathered from various primary and secondary sources, at each step, data triangulation methodologies are applied to reduce deviance and find a consistent view of the market. Each sample we share contains a detailed research methodology employed to generate the report. Please also reach our sales team to get the complete list of our data sources.

CONTACT US:

Valuates Reports
sales@valuates.com 
For U.S. Toll-Free Call 1-(315)-215-3225
For IST Call +91-8040957137
WhatsApp: +91-9945648335
Website: https://reports.valuates.com
Twitter - https://twitter.com/valuatesreports
LinkedIn - https://in.linkedin.com/company/valuatesreports
Sitemap: https://reports.valuates.com/sitemap/html/reports113
https://reports.valuates.com/sitemap/html/reports/114
https://reports.valuates.com/sitemap/html/reports/115

Logo: https://mma.prnewswire.com/media/1082232/Valuates_Reports_Logo.jpg

Modal title

Also from this source

Coolant Distribution Units for Data Centers Market to Soar as AI and HPC Drive Cooling Demand | Valuates Reports

Coolant Distribution Units for Data Centers Market to Soar as AI and HPC Drive Cooling Demand | Valuates Reports

The global market for Coolant Distribution Units (CDU) for Data Center was valued at USD 971 Million in the year 2024 and is projected to reach a...

Customized Premixes Market to Reach USD 1.47 Billion by 2030, Driven by Demand for Personalized Nutrition | Valuates Reports

Customized Premixes Market to Reach USD 1.47 Billion by 2030, Driven by Demand for Personalized Nutrition | Valuates Reports

The Global Customized Premixes Market was valued at USD 1186.1 Million in 2023 and is anticipated to reach USD 1474.2 Million by 2030, witnessing a...

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Medical Pharmaceuticals

Medical Pharmaceuticals

Pharmaceuticals

Pharmaceuticals

News Releases in Similar Topics

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.